TotalPharma: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
TotalPharma
Largest movements
- Cash +€91,165
up €91,165 (+143%), from €63,549 to €154,713
mainly Net result for the year (+€76,362) and Depreciation (+€32,403)
- Tangible fixed assets +€33,547
new in 2025: €33,547
- Intangible fixed assets -€30,000
down €30,000 (-33.3%), from €90,000 to €60,000
- Receivables within one year +€13,045
up €13,045 (+15.4%), from €84,748 to €97,793
of which Trade receivables: +€7,493
- Reserves +€76,362
up €76,362 (+45.8%), from €166,758 to €243,119
- Debts after one year +€24,915
new in 2025: €24,915
- Tax, wage and social debts -€12,451
down €12,451 (-24.0%), from €51,927 to €39,477
of which Taxes: -€15,172
- Trade debts +€11,698
up €11,698 (+70.4%), from €16,612 to €28,309
- Current portion of long-term debt +€7,636
new in 2025: €7,636
- Gross operating margin +€40,764
up €40,764 (+39.7%), from €102,713 to €143,476
- Staff costs +€10,266
new in 2025: €10,266
- Taxes +€5,126
up €5,126 (+34.0%), from €15,079 to €20,205
- Financial charges +€3,013
up €3,013 (+370%), from €815 to €3,828
- Depreciation +€2,403
up €2,403 (+8.0%), from €30,000 to €32,403
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €238,296 | €346,455 | +€108,159 | +45.4% |
| Fixed assets | 21/28 | €90,000 | €93,547 | +€3,547 | +3.9% |
| Intangible fixed assets | 21 | €90,000 | €60,000 | -€30,000 | -33.3% |
| Tangible fixed assets | 22/27 | - | €33,547 | +€33,547 | |
| Leasing and similar rights | 25 | - | €33,547 | +€33,547 | |
| Current assets | 29/58 | €148,296 | €252,908 | +€104,612 | +70.5% |
| Amounts receivable within one year | 40/41 | €84,748 | €97,793 | +€13,045 | +15.4% |
| Trade receivables | 40 | €18,873 | €26,367 | +€7,493 | +39.7% |
| Other amounts receivable | 41 | €65,874 | €71,427 | +€5,552 | +8.4% |
| Cash at bank and in hand | 54/58 | €63,549 | €154,713 | +€91,165 | +143% |
| Deferred charges and accrued income | 490/1 | - | €402 | +€402 | |
| Total equity and liabilities | 10/49 | €238,296 | €346,455 | +€108,159 | +45.4% |
| Equity | 10/15 | €169,758 | €246,119 | +€76,362 | +45.0% |
| Contributions | 10/11 | €3,000 | €3,000 | = | 0.0% |
| Reserves | 13 | €166,758 | €243,119 | +€76,362 | +45.8% |
| Distributable reserves | 133 | €166,758 | €243,119 | +€76,362 | +45.8% |
| Amounts payable | 17/49 | €68,539 | €100,336 | +€31,798 | +46.4% |
| Amounts payable after more than one year | 17 | - | €24,915 | +€24,915 | |
| Financial debts | 170/4 | - | €24,915 | +€24,915 | |
| Amounts payable within one year | 42/48 | €68,539 | €75,422 | +€6,883 | +10.0% |
| Current portion of amounts payable after more than one year | 42 | - | €7,636 | +€7,636 | |
| Trade debts | 44 | €16,612 | €28,309 | +€11,698 | +70.4% |
| Suppliers | 440/4 | €16,612 | €28,309 | +€11,698 | +70.4% |
| Taxes, remuneration and social security | 45 | €51,927 | €39,477 | -€12,451 | -24.0% |
| Taxes | 450/3 | €51,927 | €36,755 | -€15,172 | -29.2% |
| Remuneration and social security | 454/9 | - | €2,722 | +€2,722 | |
| Other amounts payable | 47/48 | €0 | €0 | = | |
| Remuneration, social security and pensions | 62 | - | €10,266 | +€10,266 | |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €30,000 | €32,403 | +€2,403 | +8.0% |
| Other operating charges | 640/8 | €182 | €477 | +€295 | +163% |
| Gross operating margin | 9900 | €102,713 | €143,476 | +€40,764 | +39.7% |
| Operating profit (loss) | 9901 | €72,531 | €100,330 | +€27,799 | +38.3% |
| Financial income | 75/76B | €64 | €65 | +€1 | +0.9% |
| Recurring financial income | 75 | €64 | €65 | +€1 | +0.9% |
| Financial charges | 65/66B | €815 | €3,828 | +€3,013 | +370% |
| Recurring financial charges | 65 | €815 | €3,828 | +€3,013 | +370% |
| Profit (loss) for the period before taxes | 9903 | €71,781 | €96,567 | +€24,786 | +34.5% |
| Income taxes | 67/77 | €15,079 | €20,205 | +€5,126 | +34.0% |
| Profit (loss) for the period | 9904 | €56,701 | €76,362 | +€19,660 | +34.7% |
| Profit (loss) for the period to be appropriated | 9905 | €56,701 | €76,362 | +€19,660 | +34.7% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 15 October 2026 via checked.be.